ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Pelthos Therapeutics Inc

Pelthos Therapeutics Inc (PTHS)

25,55
-0,31
(-1,20%)
Fermé 06 Juin 10:00PM
25,55
0,00
(0,00%)
Après les heures de négociation: 10:00PM

Pelthos Therapeutics Inc (PTHS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
25,55
( -1,20% )
Prix Achat
-
Prix Vente
-
Volume échangé
3 594
25,16 Fourchette du Jour 25,86
13,881 Plage de 52 semaines 54,29
Cap du marché
Clôture Veille
25,86
Ouverture
25,86
Dernière Transaction
100
@
25.55
Dernière heure de transaction
Volume financier
US$ 90 783
VWAP
25,2595
Volume moyen (3 m)
US$ 15 196
Actions en circulation
3 475 645
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-1,31
Bénéfice par action (BPA)
-20,19
Chiffre d'affairess (LTM)
27,7M
Bénéfice net (LTM)
-51,59M

À propos de Pelthos Therapeutics Inc

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a ... Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Durham, United States
Fondé
2026
Pelthos Therapeutics Inc est coté dans le secteur Healthcare de la American Stock Exchange avec le ticker PTHS. Le dernier cours de clôture d'Pelthos Therapeutics était de US$25,86. Au cours de la dernière année, les actions de Pelthos Therapeutics ont été négociées dans une fourchette de prix de US$ 13,881 à US$ 54,29.

Pelthos Therapeutics compte actuellement 3 475 645 actions en circulation. La capitalisation boursière d'Pelthos Therapeutics est de US$88,80 million. Pelthos Therapeutics a un ratio cours/bénéfice (ratio PE) de -1.31.

PTHS Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.54-2.0697585281726.0927.6325.38853726.13161431CS
40.20.78895463510825.3529.636524.4752363626.76232912CS
12-1.04-3.9112448288826.5929.636519.9751640625.07535506CS
26-0.85-3.219696969726.431.6218.191476125.37835111CS
529.5559.68751654.2913.8812900726.02768609CS
1569.5559.68751654.2913.8812900726.02768609CS
2609.5559.68751654.2913.8812900726.02768609CS

PTHS - Frequently Asked Questions (FAQ)

What is the current Pelthos Therapeutics Inc share price?
The current share price of Pelthos Therapeutics Inc is US$ 25,55
How many Pelthos Therapeutics Inc shares are in issue?
Pelthos Therapeutics Inc has 3 475 645 shares in issue
What is the market cap of Pelthos Therapeutics Inc?
The market capitalisation of Pelthos Therapeutics Inc is USD 88,8M
What is the 1 year trading range for Pelthos Therapeutics Inc share price?
Pelthos Therapeutics Inc has traded in the range of US$ 13,881 to US$ 54,29 during the past year
What is the PE ratio of Pelthos Therapeutics Inc?
The price to earnings ratio of Pelthos Therapeutics Inc is -1,31
What is the cash to sales ratio of Pelthos Therapeutics Inc?
The cash to sales ratio of Pelthos Therapeutics Inc is 3,32
What is the registered address of Pelthos Therapeutics Inc?
The registered address for Pelthos Therapeutics Inc is 4020 Stirrup Creek Drive, Durham, North Carolina, 27703
What is the Pelthos Therapeutics Inc website address?
The website address for Pelthos Therapeutics Inc is pelthos.com
Which industry sector does Pelthos Therapeutics Inc operate in?
Pelthos Therapeutics Inc operates in the Biotechnology & Life Sciences sector

PTHS Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion